港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

500.811

-2.736-0.54%

涨家数：9

跌家数：20

平家数：4

市盈率：- -

高：512.805

开：504.030

低：499.921

收：503.547

成交量：7,496.91万

成交额：19.33亿

市值：3,170.31亿

流通市值：2,839.18亿

数据加载中...

总览新闻资讯

亚盛医药，钢丝上的舞者

云顶新耀盘初涨超5% 公司任命两位莫德纳肿瘤疫苗科学家提速mRNA全球临床

恒瑞氟唑帕利欧盟申报获受理，PARP抑制剂国际化推进｜医药早参

每日经济新闻

港股异动 | 云顶新耀(01952.HK)早盘涨超5% 公司任命两位莫德纳肿瘤疫苗科学家提速mRNA全球临床

康方生物(09926)出现大手卖出4.8万股，成交价$105.0，涉资504万

阿斯达克财经

中金公司：有色、创新药等多领域三季报有望延续高增长

东方财富网

云顶新耀(01952)迎来两位mRNA顶尖人才加盟加速全球创新战略落地

阿斯利康两款重磅ADC药物在华获批新适应证；恒瑞医药第二款自主研发的创新药向欧盟递交上市申请丨医药早参

每日经济新闻

三季报“窗口期”将至，机构看好AI、创新药等领域，投资者该如何关注？丨经济周刊·理财

东方财富网

腾盛博药-B(02137)授出合共725.8万份购股权及授出合共138.95万份受限制股份单位

智通财经网

"70后"湖北富豪做医药"卖水人"，百普赛斯年入8亿又要IPO了！

罗克韦尔自动化携手行业领军者发起数字化 CMC 联盟，加速制药研发领域的数字化转型

核心产品海外三期研究失败艾力斯20cm跌停还带崩了创新药板块？

东方财富网

劲方医药-B(02595)10月8日斥资383.07万港元回购13.5万股

劲方医药-B(02595.HK)10月8日斥资383.07万港元回购13.5万股

众生药业(002317.SZ)：一类创新药RAY1225注射液减重III期临床试验获得顶线分析数据结果

亿腾嘉和(06998.HK)10月8日斥资148.03万港元回购88.2万股

中生制药(01177.HK)：TQC3721吸入混悬液PDE3/4抑制剂III期临床完成受试者入组

阿斯达克财经

荣昌生物(09995)截至9月末累计回购6万股

破发股汇宇制药跌10% 上市即巅峰募24.7亿中信建投保荐

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BK1574/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":500.8114,"timestamp":1791792495045,"preClose":503.54697,"halted":0,"volume":74969144,"delay":0,"changeRate":-0.005433,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-2.735565,"latestTime":"10-12 16:00:00","open":504.02963,"high":512.8047,"low":499.92114,"amount":1932609332.5,"amplitude":0.025586,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791768600000,1791777600000],[1791781200000,1791792000000]],"pbRate":3.724844,"peRate":165.446177,"turnoverRate":0.002808,"increases":9,"decrements":20,"flats":3,"marketCap":317031331104,"floatMarketCap":283917567336},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":512.8047,"amplitude":0.025586,"preClose":503.54697,"low":499.92114,"pbRate":"3.724844","latestPrice":500.8114,"volume":74969144,"delay":0,"open":504.02963,"prevYearClose":556.26263,"prevWeekClose":503.547,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":510.536,"twentyDayClose":483.155,"sixtyDayClose":473.886,"secType":"PLATE","market":"HK","turnoverRate":0.002808,"peRate":165.446177,"marketCap":317031331104,"floatMarketCap":283917567336,"timestamp":1791792495045,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":9,"down":20,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674783546","title":"亚盛医药，钢丝上的舞者","url":"https://stock-news.laohu8.com/highlight/detail?id=2674783546","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674783546?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 12:28","pubTimestamp":1791520080,"startTime":"0","endTime":"0","summary":"亚盛医药的故事，便在这两种时态之间，被无数投资者反复掂量。2026年的盛夏，亚盛医药向美国证监会递交文件，拟发行最高2亿美元美国存托凭证。02武田交易亚盛医药的研发开支主要在奥雷巴替尼（耐立克）和利沙托克拉（利生妥）。2024年6月，亚盛与武田制药就奥雷巴替尼达成海外选择权协议，换回1亿美元首付款，另有7500万美元的股权投资。钢丝上的舞者，最忌的不是走得慢，而是失去平衡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-10-09/doc-iniuqywm7008124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK4139","AAPG","06855","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674919884","title":"云顶新耀盘初涨超5% 公司任命两位莫德纳肿瘤疫苗科学家提速mRNA全球临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2674919884","media":"新浪港股","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674919884?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 09:49","pubTimestamp":1791510540,"startTime":"0","endTime":"0","summary":"模拟交易客户端云顶新耀盘初涨超5%。此次重磅引才，是云顶新耀加速推进mRNA全球战略的关键举措，将进一步强化云顶新耀mRNA技术平台的全球研发能力与国际合作布局。两位科学家将在云顶新耀管理层的领导下，重点推动云顶新耀mRNA技术平台在美国的临床开发及相关业务布局，并与中国研发团队密切协作，进一步赋能mRNA技术平台的进化。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-09/doc-iniuquqp7036894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1583","01952","159646","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674488445","title":"恒瑞氟唑帕利欧盟申报获受理，PARP抑制剂国际化推进｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2674488445","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674488445?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 09:43","pubTimestamp":1791510231,"startTime":"0","endTime":"0","summary":"截至10月8日收盘，市场全天调整，沪深两市成交额1.68万亿。医药ETF（512120）跟踪指数下跌2.75%，生物医药ETF（159508）跟踪指数下跌3.01%，港股通生物科技ETF（159102）跟踪指数下跌3.8%。相关个股中，新和成上涨1.39%、云南白药上涨0.89%、联邦制药上涨1.31%、百济神州下跌5.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093890599021.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093890599021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","09939","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884577","title":"港股异动 | 云顶新耀(01952.HK)早盘涨超5% 公司任命两位莫德纳肿瘤疫苗科学家 提速mRNA全球临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884577","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674884577?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 09:34","pubTimestamp":1791509666,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","01952","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884941","title":"康方生物(09926)出现大手卖出4.8万股，成交价$105.0，涉资504万","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884941","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674884941?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 09:30","pubTimestamp":1791509400,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午09:30出现大手卖出，成交量为4.8万，成交价为港币$105.0，涉资504万。至目前为止，股价跌0.378%，今日最高价为$105.9，而最低价为$105.0，总成交量为14.368万股，总成交金额港币$1.523千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144028088_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144028088_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26100981/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT26100981/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0634319403.HKD","LU1720050803.USD","09926","LU0561508036.HKD","LU2476274308.USD","IE00B543WZ88.USD","LU0540923850.HKD","BK1161","LU2488822045.USD","LU2399975544.HKD","IE00B5MMRT66.SGD","LU0348766576.USD","LU2476274720.SGD","LU0348735423.USD","LU0348827113.USD","LU0348783233.USD","LU0348767384.USD","LU0417516571.SGD","IE00BPRC5H50.USD","LU2778985437.USD","LU0417516902.SGD","KURE","LU1961090484.USD","LU0417516738.SGD","BK1574","LU0348825331.USD","LU1794554557.SGD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884452","title":"中金公司：有色、创新药等多领域三季报有望延续高增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884452","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674884452?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 09:14","pubTimestamp":1791508445,"startTime":"0","endTime":"0","summary":"新华财经上海10月9日电中金公司研报分析认为，三季报A股整体盈利增速或环比回落，结构分化延续，上游能源原材料及TMT领域有望延续较高增长。结合行业分析师自下而上的观察视角，部分有色金属、受益于AI高景气与海外需求的科技硬件、创新药、CXO、水电核电、工程机械、液冷、集运油运、白酒、免税、旅游、游戏等领域三季报盈利增速有望较中报继续改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202610093890505926.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202610093890505926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LNGR","LU1580142542.USD","BK1574","BK1564","LU2663582299.SGD","SG9999002828.SGD","BK1516","03908","BK1161","MEDX","IBBQ","LU1508157978.USD","BK1501","BK1147","LU2351347302.SGD","159992","LU1023057109.AUD","LU2929501877.USD","LU0359201612.USD","LU0259732245.USD","159876","LU0359201885.HKD","601995","BK0276","LU2187417386.USD","LU0359202008.SGD","LU1781817850.SGD","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674881838","title":"云顶新耀(01952)迎来两位mRNA顶尖人才加盟 加速全球创新战略落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2674881838","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674881838?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 08:53","pubTimestamp":1791507195,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月9日，云顶新耀宣布任命Lakshmi Srinivasan博士担任高级副总裁、转化医学负责人，Brandon Coder博士担任转化科学与早期研究副总裁。此次任命将进一步强化云顶新耀mRNA技术平台的全球研发能力与国际合作布局。未来，公司将持续汇聚国际化顶尖人才，整合研发资源，加速全球创新战略落地。此次任命体现了云顶新耀持续汇聚全球顶尖人才、推进全球mRNA战略的承诺。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云顶新耀(01952)迎来两位mRNA顶尖人才加盟 加速全球创新战略落地","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885482","title":"阿斯利康两款重磅ADC药物在华获批新适应证；恒瑞医药第二款自主研发的创新药向欧盟递交上市申请丨医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885482","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674885482?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 07:00","pubTimestamp":1791500422,"startTime":"0","endTime":"0","summary":"丨2026年10月9日星期五丨NO.1阿斯利康两款重磅ADC药物在华获批新适应证10月8日，阿斯利康宣布，由阿斯利康和第一三共联合开发和商业化的达卓优（通用名：注射用德达博妥单抗）于9月29日正式获得国家药监局批准，用于治疗不适合接受PD-1/PD-L1抑制剂治疗的不可切除或转移性三阴性乳腺癌成人患者。同日，阿斯利康还宣布，优赫得（通用名：注射用德曲妥珠单抗）也在中国获批。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093890074039.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093890074039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2543165471.USD","159992","BK0188","LNGR","LU0359201885.HKD","LU0405327148.USD","LU1997244956.HKD","LU2097828631.EUR","LU2289578879.USD","LU1255011170.USD","LU1997245094.SGD","159938","LU1064130708.USD","BK0196","LU2328871848.SGD","01276","LU2097828557.USD","BK1161","LU2488822045.USD","LU2097828714.EUR","LU0359202008.SGD","09939","BK0012","LU1146622755.USD","MEDX","BK0028","BK0239","BK1191","06978","600276","LU0405327494.USD","LU2580892862.HKD","LU2097828474.EUR","BK0060","LU1328615791.USD","LU0359201612.USD","LU1781817850.SGD","LU1969619763.USD","LU1580142542.USD","LU2580892789.USD","IBBQ","LU1655091616.SGD","LU2495084118.USD","LU1997245177.USD","LU2097828805.USD","BK0183","BK1574","IPOS","BK1515","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674004604","title":"三季报“窗口期”将至，机构看好AI、创新药等领域，投资者该如何关注？丨经济周刊·理财","url":"https://stock-news.laohu8.com/highlight/detail?id=2674004604","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674004604?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 00:08","pubTimestamp":1791475680,"startTime":"0","endTime":"0","summary":"长假后A股开盘首日，市场震荡调整，三大指数集体冲高回落，科创50指数低开低走。一方面是权重股银行股在震荡走强，另一方面是热门赛道CPO概念持续走弱，半导体产业链震荡调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1405,202610093890023621.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1405,202610093890023621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LNGR","06978","CHAT","IBBQ","AGIX","MEDX","ARTY","159992","BK1161","BK1574","VTHR","QTOC","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673958003","title":"腾盛博药-B(02137)授出合共725.8万份购股权及授出合共138.95万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2673958003","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673958003?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 22:11","pubTimestamp":1791468668,"startTime":"0","endTime":"0","summary":"腾盛博药-B(02137)发布公告，于2026年10月8日，本公司根据2023年购股权计划条款向63名购股权受让人授出合共725.8万份购股权，惟须待购股权受让人接纳。于本公告日期，已发行股份总数为7.22亿股(不包括库存股)。根据授出购股权授出的该等购股权获悉数行使后，据此将配发及发行的股份占本公告日期已发行股份总数(不包括库存股)约1.0%及经扩大已发行股份总数约1.0%(不包括库存股及根据授出受限制股份单位授予受限制股份单位受让人的任何受限制股份单位的归属情况)。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg27.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg27.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1587","02137","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673070141","title":"\"70后\"湖北富豪做医药\"卖水人\"，百普赛斯年入8亿又要IPO了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2673070141","media":"野马财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673070141?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 21:04","pubTimestamp":1791464640,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/L8OE095S0519875F.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/L8OE095S0519875F.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["09939","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673300348","title":"罗克韦尔自动化携手行业领军者发起数字化 CMC 联盟，加速制药研发领域的数字化转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2673300348","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673300348?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 21:00","pubTimestamp":1791464400,"startTime":"0","endTime":"0","summary":"罗克韦尔自动化携手行业领军者发起数字化CMC 联盟，加速制药研发领域的数字化转型  制药企业面临着越来越大的压力，需要在满足复杂监管要求的同时，加快研发进程并控制不断上涨的成本。\"罗克韦尔自动化全球生命科学行业副总裁Matt Weaver 表示，\"该联盟体现了推动制药行业发展的合作导向模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5066142_ZH66142_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5066142_ZH66142_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0511384066.AUD","LU1988902786.USD","LU0124676726.USD","BK4580","LU1894683348.USD","LU0289739343.SGD","XSW","BK4585","BK4588","LU0154245756.USD","LU2264538146.SGD","01477","LU0057025933.USD","LU0154245673.USD","LU1064131342.USD","THMZ","LU0289961442.SGD","LU1894683264.USD","LU0069063385.USD","LU0689626769.HKD","BK4096","BK1574","LU0472753341.HKD","BK1191","MVPS","ROK","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673741340","title":"核心产品海外三期研究失败 艾力斯20cm跌停 还带崩了创新药板块？","url":"https://stock-news.laohu8.com/highlight/detail?id=2673741340","media":"东方财富网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673741340?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:51","pubTimestamp":1791460260,"startTime":"0","endTime":"0","summary":"【核心产品海外三期研究失败 艾力斯20cm跌停 还带崩了创新药板块？】10月8日，A股多家药企股价下跌明显。具体来看，艾力斯20%跌停，丽珠集团10%跌停，亚虹医药跌超11%，益方生物、百奥泰、三生国健等跌超7%。业内普遍认为，此次创新药板块集体下挫的导火索是国内创新药企艾力斯的三期临床试验失败的负面消息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202610083889811123.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202610083889811123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688578","BK1574","MEDX","LNGR","BK0239","159992","06978","IBBQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074377","title":"劲方医药-B(02595)10月8日斥资383.07万港元回购13.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074377?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:43","pubTimestamp":1791459805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年10月8日斥资383.07万港元回购13.5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","159938","BK1515","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074306","title":"劲方医药-B(02595.HK)10月8日斥资383.07万港元回购13.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074306","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074306?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:43","pubTimestamp":1791459805,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1515","BK1574","02595","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673071276","title":"众生药业(002317.SZ)：一类创新药RAY1225注射液减重III期临床试验获得顶线分析数据结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2673071276","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673071276?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 19:35","pubTimestamp":1791459349,"startTime":"0","endTime":"0","summary":"智通财经APP讯，众生药业 发布公告，公司控股子公司广东众生睿创生物科技有限公司自主研发的一类创新多肽药物RAY1225注射液在超重或肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验，于近日获得顶线分析数据。REBUILDING-2临床试验于近日完成数据清理和锁定，获得顶线分析结果，达到主要终点。RAY1225注射液在主要有效性指标以及多种心血管和代谢危险因素改善等多个关键次要有效指标均显著优于安慰剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","LNGR","BK0077","PSYK","BK1574","MEDX","IBBJ","BMED","MDTX","06978","BK1161","BK0239","002317","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673281075","title":"亿腾嘉和(06998.HK)10月8日斥资148.03万港元回购88.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673281075","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673281075?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 18:19","pubTimestamp":1791454748,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1161","06998","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673073530","title":"中生制药(01177.HK)：TQC3721吸入混悬液PDE3/4抑制剂III期临床完成受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2673073530","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673073530?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 17:43","pubTimestamp":1791452580,"startTime":"0","endTime":"0","summary":"中生制药(01177.HK) 公布，附属公司正大天晴主研发的国家1类创新药TQC3721吸入混悬液“PDE3/4抑制剂”用于慢性阻塞性肺疾病(COPD)维持治疗的关键注册III期临床试验(PACER-III)，已于近期完成全部受试者入组。(sl/ad)(港股报价延迟最少十五分钟。沽空资料截至 2026-10-08 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1548382/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1548382/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01477","01177","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1574","BK1515","BK1589","HK0000165453.HKD","BK1521","BK1191","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673707882","title":"荣昌生物(09995)截至9月末累计回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673707882","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673707882?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 17:27","pubTimestamp":1791451634,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(09995)发布公告，截至2026年9月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份6万股，占公司总股本5.64亿股的比例为0.0106%，回购成交的最高价为113.7元/股，最低价为108.30元/股，支付的资金总额为人民币663.2万元(不含交易佣金等交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09995","BK1161","LU2148510915.USD","LU1064130708.USD","LU2328871848.SGD","LU2488822045.USD","BK1583","LU1064131003.USD","BK1574","LU1969619763.USD","688331","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673020130","title":"破发股汇宇制药跌10% 上市即巅峰募24.7亿中信建投保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2673020130","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673020130?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 17:03","pubTimestamp":1791450185,"startTime":"0","endTime":"0","summary":"中国经济网北京10月8日讯 汇宇制药 今日收报11.55元，跌幅10.12%。目前该股处于破发状态。　　上市当日，汇宇制药盘中最高报42.59元，创上市以来股价最高点。　　汇宇制药发行募集资金总额为24.72亿元，扣除发行费用后，募集资金净额为23.61亿元。　　汇宇制药发行费用合计1.11亿元，其中中信建投证券、国都证券获得承销费9887.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261008/32390272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","BK1574","601066","BK0276","01477","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":3,"totalSize":249,"code":"91000000","status":"200"}]}}